CPC C07D 405/14 (2013.01) [A61K 31/506 (2013.01); A61K 45/06 (2013.01); C07D 401/14 (2013.01); C07D 409/14 (2013.01); A61P 3/00 (2018.01); A61P 3/06 (2018.01); A61P 3/10 (2018.01); C07B 2200/13 (2013.01)] | 10 Claims |
1. A method for treating hyperlipidemia, dyslipidemia,
atherosclerosis, hypertriglyceridemia, or hyper apo B lipoproteinemia, in humans comprising the step of administering to a human in need of such treatment a therapeutically effective amount of a compound according to Formula (I) or a pharmaceutically acceptable salt of said compound;
wherein
D1 and D2 are each independently N or CH;
R1 is H, or (C1-C2)alkyl optionally substituted with one or two substituents each independently selected from fluoro and (C3-C6)cycloalkyl;
R2 is H or fluoro;
R3 is,
R4 is H, cyano, or (C1-C4)alkyl optionally substituted with one or two substituents each independently selected from —OH and —S(O)2R6;
R5 is H or —OH, and
R6 is (C1-C4)alkyl.
|